1475-2891-7-4 1475-2891 Short report <p>Relationships of low serum vitamin D<sub>3 </sub>with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity</p> McGill Anne-Thea at.mcgill@auckland.ac.nz Stewart M Joanna j.stewart@auckland.ac.nz Lithander E Fiona fiona.lithander@tcd.ie Strik M Caroline c.strik@auckland.ac.nz Poppitt D Sally s.poppitt@auckland.ac.nz

University of Auckland Human Nutrition Unit, University of Auckland, Auckland, New Zealand

School of Biological Sciences, University of Auckland, Auckland, New Zealand

School of Medical Science, University of Auckland, Auckland, New Zealand

School of Population Health, University of Auckland, Auckland, New Zealand

 Nutrition Journal 1475-2891 2008 7 1 4 http://www.nutritionj.com/content/7/1/4 18226257 10.1186/1475-2891-7-4 19 6 2006 28 1 2008 28 1 2008 2008 McGill et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Low serum 25 hydroxyvitamin D3 (vitamin D3) is known to perturb cellular function in many tissues, including the endocrine pancreas, which are involved in obesity and type II diabetes mellitus (TIIDM). Vitamin D3 insufficiency has been linked to obesity, whether obesity is assessed by body mass index (BMI) or waist circumference (waist). Central obesity, using waist as the surrogate, is associated with the metabolic syndrome (MetSyn), insulin resistance, TIIDM and atherosclerotic cardiovascular disease (CVD). We tested how vitamin D3 was related to measures of fat mass, MetSyn markers, haemoglobin A1c (HbA1c) and MetSyn in a cross-sectional sample of 250 overweight and obese adults of different ethnicities. There were modest inverse associations of vitamin D3 with body weight (weight) (r = -0.21, p = 0.0009), BMI (r = -0.18, p = 0.005), waist (r = -0.14, p = 0.03), [but not body fat % (r = -0.08, p = 0.24)], and HbA1c (r = -0.16, p = 0.01). Multivariable regression carried out separately for BMI and waist showed a decrease of 0.74 nmol/L (p = 0.002) in vitamin D3 per 1 kg/m2 increase in BMI and a decrease of 0.29 nmol/L (p = 0.01) per 1 cm increase in waist, with each explaining approximately 3% of the variation in vitamin D3 over and above gender, age, ethnicity and season.

The similar relationships of BMI and waist with vitamin D3 may have been due to associations between BMI and waist, or coincidental, where different mechanisms relating hypovitaminosis D3 to obesity occur concurrently. Previously reviewed mechanisms include that 1) low vitamin D3, may impair insulin action, glucose metabolism and various other metabolic processes in adipose and lean tissue 2) fat soluble-vitamin D3 is sequestered in the large adipose compartment, and low in serum, 3) obese people may be sensitive about their body shape, minimising their skin exposure to view and sunlight (not tested). We showed evidence for the first theory but no evidence to support the second.

In the current study, serum vitamin D3 was inversely related to weight, BMI and markers of TIIDM (large waist, raised HbA1c) but not to adipose mass nor to MetSyn per se.

Background

It is now known that insufficient serum 25 hydroxyvitamin D3 (calcifediol, vitamin D3) alters metabolite function causing perturbation of many cellular functions, including that of the endocrine pancreas 1. Recently, there has been a resurgence of hypovitaminosis D3 in many populations 2, including young, pale-skinned adults 3 in addition to those with pigmented skin. Suggested recent recommendations of ideal vitamin D3 serum levels for metabolic health are >70–100 nmol/L (previously >50 nmol/L) 45. In parallel, there has been a world-wide increase in the prevalence of obesity 6. Links between hypovitaminosis D3 and obesity have been reported when obesity is defined using body mass index (BMI) 78 and waist circumference (waist) 9. Large waist, a surrogate for abdominal obesity, is the key marker required for the metabolic syndrome (MetSyn) as defined by the International Diabetes Federation (IDF) 10. Whilst there is overlap in total body and abdominal obesity, the diverse metabolic processes of different adipose depots and lean tissue may underpin dissimilar hypotheses for the mechanisms proposed for the inverse relationship of vitamin D3 and obesity.

This study was designed to 1) assess the relationships between vitamin D3 and anthropometric, metabolic syndrome and TIIDM markers, 2) determine whether whole body [BMI] or central [waist] adiposity was significantly related to vitamin D3, and if so whether one was related independently of the other when corrected for well-known influences in mixed-ethnicity adults.

Methods

Population and anthropometry

250 ambulant adults in Auckland, New Zealand were recruited into a body weight (weight) loss trial with primary criteria including BMI 28–50 kg/m2, age >18 y, not currently using weight loss agents nor participating in commercial weight loss programmes, and a desire to lose weight. Baseline data from this study were analysed for relationships with vitamin D3. Ethnicity was the surrogate for skin pigment. The lightly pigmented skin sub-group consisted of Caucasians and the variably pigmented skin sub-group included all other ethnicities which were New Zealand Maori, Pacific Peoples (Tongan, Samoan,) and Asian (East, South or Indian). For anthropometry, participants were lightly clad and measurements were taken in duplicate. Weight, height, waist and blood pressure were measured using standard methods as detailed in our previous publication 11. Body fat percentage (fat%) was assessed indirectly by multi-frequency bioelectrical impedance analysis (SFB3 MFBIA, Impedimed, Australia). All participants provided written informed consent. Ethics approval for this study was obtained from the Auckland Ethics Committee, Auckland, New Zealand.

Laboratory samples

Participants attended our community clinic for collection of fasting blood. 200 women and 43 men provided evaluable samples. Vitamin D3 was analysed using Vit D25 pre-extraction with acetonitrile, double antibody radioimmunoassay (DiaSorin Inc Stillwater, MN, USA). Fasting plasma glucose (FPG), serum lipids and haemoglobin A1c (HbA1c) were measured using standard methods 11.

Statistical Analysis

Linear regression analysis was used to investigate the relationships of the demographic data, anthropometry and laboratory tests with vitamin D3. Multivariable regression was performed with vitamin D3 as the outcome variable. Explanatory variables were gender, age, ethnicity, season, and either BMI or waist as these were likely to be highly correlated. An analysis including both BMI and waist was also carried out to investigate if one variable contributed over and above the other. SAS 8.0 statistical software (Cary, NC, 2003) was employed for analyses.

Results

Baseline data shows an obese population with prevalences of MetSyn and TIIDM ≈ 40% and 5% in 234 participants with available FPG. Table 1.

<p>Table 1</p>

Baseline data from 250 female and male overweight and obese participants

Parameter

Evaluable N 1

Mean(SD)

Age (y)

243

47.6(11.6)

Weight (kg)

243

97.3(18.2)

Height (cm)

243

166(8)

Body mass index (kg/m2)

243

35.4(5.2)

Body fat (%)

243

38.2(6.6)

2Waist (cm)

243

100.4(12.8)

2Systolic blood pressure (mmHg)

243

123(18)

2Diastolic blood pressure (mmHg)

243

70(10)

2Triglyceride (mmol/L)

243

1.56(0.82)

2High density lipoprotein-cholesterol (mmol/L)

243

1.33(0.34)

2Fasting plasma glucose (mmol/L)

234

5.32(1.38)

Haemoglobin A1c (%)

217

5.25(0.82)

2Metabolic syndrome marker count

234

2.4(1.1)

Vitamin D 3 nmol/L*

Total

243

62.2(22.7)

Women

200

62.4(21.9)

Men

43

61.7(26.3)

Skin pigment, light

206

64.8(22.0)

Skin pigment, variable

37

47.5(20.0)

Summer

141

68.7(21.9)

Winter

102

53.3(20.6)

2Metabolic syndrome, no

135

61.4(22.8)

2Metabolic syndrome, yes

99

63.8(22.4)

Non-type II diabetes mellitus

223

62.7(22.7)

Type II diabetes mellitus

11

55.5(20.1)

* Raw data in pair sets. See text for multivariable regression results. 1Although anthropometry was collected on all 250 participants, data is only shown for 243, as evaluable serum samples for vitamin D3 analysis were available for this number (N) only. 6 samples were not obtained due to unsuccessful venepuncture and 1 sample was lost in transit to the laboratory. For the sub-groups some samples were not evaluable due to sample quality or loss. Sample number (N) is shown for each category. 2 Metabolic syndrome (N=234) is defined by the International Diabetes Federation as 1) Waist circumference: Europids and Undefined groups [such as Maori and Pacific Peoples] ≥ 94 cm (men), ≥ 80 cm (women), Asian (based on a Chinese, Malay and Indian Asian population) ≥ 90 cm (men) and ≥ 80 cm (women). Waist must be included, plus two or more of 2) Systolic and diastolic blood pressure ≥ 130/85 mmHg, 3) High density lipoprotein – cholesterol <1.03 mmol/L (<40 mg/dL) men, <1.29 mmol/L (<50 mg/dL) women 4) Triglyceride ≥ 1.69 mmol/L (150 mg/dL) 5) Fasting plasma glucose ≥ 5.6 mmol/L (≥ 100 mg/dL) and/or on treatment medication for the latter 4 conditions.

There were modest but significant inverse relationships of vitamin D3 with weight (p = 0.0009), BMI (p = 0.005) and waist (p = 0.03) but no relationship could be shown with fat %. Figure 1. Vitamin D3 could not be shown to be related to any of the non-waist MetSyn markers (MetSynM) or MetSynMcount (number of markers added together) or the presence of MetSyn (p > 0.05, all). Vitamin D3 and HbA1c, alone of the individual metabolic and MetSynM were weakly inversely related (p = 0.01) but this relationship was not significant after exclusion of the three HbA1c values >10% (p = 0.22). Abnormal FPG was related to hypovitaminosis D3, again only when the three values >10 mmol/L were included (r2 = 0.17, p = 0.005). Figure 1.

<p>Figure 1</p>

The relationship between vitamin D3 and anthropometric and metabolic markers in 250 overweight and obese men and women

The relationship between vitamin D3 and anthropometric and metabolic markers in 250 overweight and obese men and women.

Multivariable regression showed an estimated decrease of 0.74 nmol/L (p = 0.002) in vitamin D3 per 1 kg/m2 increase in BMI with the total model explaining 22% of the variation in vitamin D3 levels and BMI explaining 3% of the variation. On replacing BMI with waist, there was a decrease of 0.29 nmol/L (p = 0.01) vitamin D3 per 1 cm increase in waist, with the total model explaining 21% of the variation in vitamin D3 and waist explaining 3%. When both BMI and waist were included neither could be demonstrated to contribute over and above the other (p = 0.25 and 0.67 respectively), nor could an association of vitamin D3 with gender (p = 0.52) or age (p = 0.52) be shown. However there was strong evidence of its association with ethnicity (p < 0.0001) and season (p < 0.0001).

Discussion

In the current study we showed that low levels of circulating vitamin D3 were inversely related to markers of TIIDM (large waist and raised HbA1c), rather than total adipose mass, non-waist MetSynM or MetSyn per se.

Of the three anthropometric variables that were significantly inversely correlated with vitamin D3 only BMI and waist were further investigated as weight is considered too crude a measure of obesity. Vitamin D3 showed inverse relationships separately, but of the same magnitude, with both BMI and waist when corrected for confounders. Neither could be shown to be related to vitamin D3 given the level of the other. This may indicate either similar mechanisms, or that different metabolic processes are occurring, coincidentally producing similar outcomes.

Hypotheses from the literature are discussed in light of our findings

Whole body obesity, as defined by BMI, has been associated with or contributes to low vitamin D3 status 812. Wortsman et al., found lower vitamin D3 in the serum of obese participants after experimental UV irradiation, deducing that "obesity-associated vitamin D insufficiency is likely due to the decreased bioavailability of vitamin D3 from cutaneous and dietary sources because of its deposition in body fat compartments" 12. It was unclear from that trial which fat compartments were involved. In the current study MFBIA fat% did not correlate with vitamin D3, in contrast to that of Arunabh et al., 13 where DEXA was performed in women, BMI<24 kg/m2. Total body fat includes both peripheral adipose at the hip and thigh, with beneficial metabolic effects in both women and men 14, as well as less healthy upper body and central fat depots 15. The opposing effects of these adipose depots could possibly weaken any correlation with vitamin D3. Furthermore, the lack of relationship of fat% with vitamin D3 may reflect influences of fat-free compartments of bone, muscle 16 and abdominal organs (liver, kidney, gut 17).

The links between the metabolic syndrome and vitamin D3 are not clear. In the present study, apart from waist, none of MetSynM alone, MetSynMcount, nor the presence of MetSyn (defined by three of five positive markers 9), was correlated with vitamin D3. This lack of relationship of vitamin D3 and MetSyn has been reported previously 18, and two studies of vitamin D3 in the morbidly obese report conflicting relationships 1920. However, in the large USA NHANES dataset Ford et al., found that abdominal obesity as measured by waist alone, in addition to MetSyn, was related to low vitamin D3, notably affecting mixed-ethnicity participants equally 21.

Conversion of vitamin D3 to its derivative 1,25 vitamin D3 is complex and involves other hormones. 1,25 vitamin D3, via its receptor which is present in insulin-producing beta-islet cells, is known to be a potent regulator of cell proliferation and differentiation 2223. However, there is evidence that low vitamin D3 itself is associated with TIIDM irrespective of 1,25 vitamin D3 8. The inverse relationship of vitamin D3 with high to extreme HbA1c 2425 and/or FPG 78 may indicate that it is the long-term, severely abnormal (carbohydrate) metabolism of TIIDM 72627 and muscle insulin resistance 28, that is associated with hypovitaminosis D3. HbA1c, a glycated protein, is a predictor of 2-hour glucose in oral glucose tolerance testing, 29 an indicator of chronic hyperglycaemia, protein glycation damage 30 and oxidative stress 31. Many new, profound and interacting mechanisms link hypovitaminosis D with other correlates of the metabolic syndrome, including renin regulation 1. Vitamin D-upregulated protein-1 reportedly modulates endothelial oxidative stress, macrophage and smooth muscle function, depending on the stage of atherosclerosis 3233.

Limitations of the present study include the cross sectional design where cause cannot be attributed. Lifestyle, body shape sensitivity 3435 or cultural reasons 36 for precluding skin exposure to view, and ultraviolet light for efficient vitamin D3 synthesis, may selectively affect obese people but were not examined.

In the current study low serum vitamin D3 was inversely related to weight and BMI, but not fat mass, and to markers indicative of TIIDM (large waist and raised HbA1c), rather than MetSyn per se. The link between hypovitaminosis D3 and metabolic disorders, including obesity, MetSyn, TIIDM and CVD requires further investigation, particularly for those most at risk of these combined conditions.

Abbreviations

vitamin D3: serum 25 hydroxyvitamin D3; TIIDM: type II Diabetes Mellitus; BMI: body mass index; waist: waist circumference; weight: body weight; fat%: body fat percentage; MFBIA: multi-frequency bioelectrical impedance analysis; DEXA: dual energy x-ray absorptiometry; MetSyn: metabolic syndrome; MetSynM: metabolic syndrome marker; MetSynMcount: metabolic syndrome marker count (the number of metabolic syndrome markers added together, ranging from 0–5. A count of 3, obligatorily including waist, indicates the metabolic syndrome); CVD: atherosclerotic cardiovascular disease; FPG: fasting plasma glucose; S/DBP: systolic/diastolic blood pressure; TAG: triglyceride; HDL-C: high density lipoprotein-cholesterol; HbA1c: haemoglobin A1c; IDF: International Diabetes Federation.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

ATM conceived the study and was the senior author during manuscript preparation. ATM, FEL, SDP and CMS contributed to the planning, conduct, and reporting of this study. JMS, ATM and CMS did the data entry and statistical analysis. ATM, FEL, SDP and CMS contributed to manuscript preparation. All authors read and approved the final manuscript. Funds were raised by ATM and SDP as part of a wider programme grant.

Acknowledgements

We thank the Health Research Council of New Zealand for funding the main ECHO trial and Healtheries Ltd, New Zealand for funding the vitamin D3 assays. We also thank the Clinical Trials Research Unit, University of Auckland, Jane Easton (Study Manager), Santuri Rungan, Chao-Yuan Chen, David Anderson, Laura Gerulitis, Pia Nielson, Jeannette Eis, Cathelijne Reincke, Shannon McCarthy, Jenneke van Drunen (Research Assistants) and the 250 participants.

 <p>Vitamin D deficiency</p> Holick MF N Engl J Med 2007 357 3 266 281 10.1056/NEJMra070553 17634462 <p>SOLAR ultraviolet radiation and vitamin D: a historical perspective</p> Rajakumar K Greenspan SL Thomas SB Holick MF Am J Public Health 2007 97 10 1746 1754 10.2105/AJPH.2006.091736 17761571 <p>Vitamin D insufficiency among free-living healthy young adults</p> Tangpricha V Pearce EN Chen TC Holick MF Am J Med 2002 112 8 659 662 10.1016/S0002-9343(02)01091-4 12034416 <p>The urgent need to recommend an intake of vitamin D that is effective</p> Vieth R Bischoff-Ferrari H Boucher BJ Dawson-Hughes B Garland CF Heaney RP Holick MF Hollis BW Lamberg-Allardt C McGrath JJ Am J Clin Nutr 2007 85 3 649 650 17344484 <p>Dose response to vitamin D supplementation among postmenopausal African American women</p> Talwar SA Aloia JF Pollack S Yeh JK Am J Clin Nutr 2007 86 6 1657 1662 18065583 <p>Obesity, Metabolic Syndrome, and Cardiovascular Disease</p> Grundy SM J Clin Endocrinol Metab 2004 89 6 2595 2600 10.1210/jc.2004-0372 15181029 <p>Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus</p> Scragg R Holdaway I Singh V Metcalf P Baker J Dryson E Diabetes Res Clin Pract Suppl 1995 27 3 181 188 10.1016/0168-8227(95)01040-K <p>Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women</p> Need AG O'Loughlin PD Horowitz M Nordin BC Clin Endocrinol (Oxf) 2005 62 6 738 741 10.1111/j.1365-2265.2005.02288.x 15943837 <p>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report</p> National Cholesterol Education Program Expert Panel Circulation 2002 106 25 3143 3421 12485966 <p>The IDF consensus worldwide definition of the metabolic syndrome</p> http://www.idf.org/webdata/docs/MetS_def_update2006.pdf <p>The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults</p> Ni-Mhurchu C Poppitt SD McGill A-T Leahy FE Bennett DA Lin RB Ormrod D Ward L Strik C Rodgers A Int J Obes Relat Metab Disord 2004 28 9 1149 1156 10.1038/sj.ijo.0802693 15311218 <p>Decreased bioavailability of vitamin D in obesity</p> Wortsman J Matsuoka LY Chen TC Lu Z Holick MF Am J Clin Nutr 2000 72 3 690 693 10966885 <p>Body fat content and 25-hydroxyvitamin D levels in healthy women</p> Arunabh S Pollack S Yeh J Aloia JF J Clin Endocrinol Metab 2003 88 1 157 161 10.1210/jc.2002-020978 12519845 <p>Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study</p> Snijder MB Dekker JM Visser M Bouter LM Stehouwer CD Kostense PJ Yudkin JS Heine RJ Nijpels G Seidell JC Am J Clin Nutr 2003 77 5 1192 1197 12716671 <p>Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model</p> Jensen MD Obes Res 2006 14 suppl_2 20S 24 <p>Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect?</p> Arabi A Baddoura R Awada H Salamoun M Ayoub G El-Hajj Fuleihan G Bone 2006 39 2 268 275 10.1016/j.bone.2006.01.140 16495164 <p>Osteoporosis. Part III–Not just for bone loss: potential benefits of calcium and vitamin D for overall general health</p> Moyad MA Urol Nurs 2003 23 1 69 74 12677721 <p>Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults</p> Reis JP von Muhlen D Kritz-Silverstein D Wingard DL Barrett-Connor E Diabetes Care 2007 30 6 1549 1555 10.2337/dc06-2438 17351276 <p>Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity</p> Botella-Carretero J Alvarez-Blasco F Villafruela J Balsa J Vazquez C Escobar-Morreale H Clin Nutr 2007 17624643 <p>Vitamin D, PTH, and the Metabolic Syndrome in Severely Obese Subjects</p> Rueda S Fernández-Fernández C Romero F Martínez de Osaba M Vidal J Obesity Surgery 2008 Jan 4 18175193 <p>Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults</p> Ford ES Ajani UA McGuire LC Liu S Diabetes Care 2005 28 5 1228 1230 10.2337/diacare.28.5.1228 15855599 <p>Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease</p> Holick MF Am J Clin Nutr 2004 80 Suppl 6 1678S 1688S <p>Association of low intake of milk and vitamin D during pregnancy with decreased birth weight</p> Mannion CA Gray-Donald K Koski KG Can Med Assoc J 2006 174 9 1273 1277 10.1503/cmaj.1041388 <p>Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values</p> Woerle HJ Pimenta WP Meyer C Gosmanov NR Szoke E Szombathy T Mitrakou A Gerich JE Arch Intern Med 2004 164 15 1627 1632 10.1001/archinte.164.15.1627 15302632 <p>Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?</p> Osei K Rhinesmith S Gaillard T Schuster D J Clin Endocrinol Metab 2003 88 10 4596 4601 10.1210/jc.2003-030686 14557428 <p>Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'?</p> Boucher BJ Br J Nutr 1998 79 4 315 327 10.1079/BJN19980055 9624222 <p>Vitamin D and Calcium Intake in Relation to Type 2 Diabetes in Women</p> Pittas AG Dawson-Hughes B Li T Dam RMV Diabetes Care 2006 29 3 650 657 10.2337/diacare.29.03.06.dc05-1961 16505521 <p>Assessment of endocrine and nutritional status in age-related catabolic states of muscle and bone</p> Lytras A Tolis G Curr Opin Clin Nutr Metab Care 2007 10 5 604 610 10.1097/MCO.0b013e3282cfa32f 17693744 <p>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.[comment]</p> Alberti KG Zimmet PZ Diabetic Medicine 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693 <p>Glucose control in diabetes</p> Valeri C Pozzilli P Leslie D Diabetes Metab Res Rev 2004 20 Suppl 2 S1 8 10.1002/dmrr.512 15551299 <p>Oxidative stress indices in IDDM subjects with and without long-term diabetic complications</p> VanderJagt DJ Harrison JM Ratliff DM Hunsaker LA Vander Jagt DL Clin Biochem 2001 34 4 265 270 10.1016/S0009-9120(01)00204-1 11440725 <p>Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage</p> Billiet L Furman C Larigauderie G Copin C Page S Fruchart JC Brand K Rouis M J Cell Physiol 2008 214 1 183 191 10.1002/jcp.21179 17579352 <p>Vitamin D Deficiency and Risk of Cardiovascular Disease</p> Wang TJ Pencina MJ Booth SL Jacques PF Ingelsson E Lanier K Benjamin EJ D'Agostino RB Wolf M Vasan RS Circulation 2008 January 7 <p>Vitamin D status and bone histomorphometry in gross obesity</p> Compston J Ledger J Webb A Gazet J Pilkington T Vedi S Am J Clin Nutr 1981 34 2359 2363 7304477 <p>Development of the body dysmorphic disorder examination</p> Rosen JC Reitera J Behav Res Ther 1996 34 9 755 766 10.1016/0005-7967(96)00024-1 8936758 <p>Vitamin D and muscle function</p> Pfeifer M Begerow B Minne HW Osteoporos Int 2002 13 3 187 194 10.1007/s001980200012 11991436